Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Nickerson to lead Therini as CEO

Plus: Alex Gorsky joins  Iconiq Capital and updates from JPMorgan and Merakris

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst  
May 10, 2024 10:30 PM UTC

Tara Nickerson became CEO of Therini Bio Inc., which is developing fibrin-targeting immunotherapies for retinal and neurological diseases. Nickerson was CBO at Maze Therapeutics Inc. and Prothena Corp. plc (NASDAQ:PRTA).

Alex Gorsky, former chairman and CEO of Johnson & Johnson (NYSE:JNJ), joined San Francisco investment management firm Iconiq Capital as general partner. Gorsky is on the boards of Apple Inc. (NASDAQ:APPL), IBM (NYSE:IBM), J.P. Morgan Chase & Co. (NYSE:JPM) and the Travis Manion Foundation...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Iconiq Capital

JPMorgan Chase

Merakris Therapeutics Inc.

Therini Bio Inc.